Duavive HRT: conjugated oestrogens with bazedoxifene

Abstract

Duavive is a new oral HRT formulation containing conjugated oestrogens and the selective oestrogen‐receptor modulator bazedoxifene and is indicated for the treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus who cannot take progestogencontaining therapy. This article discusses its properties, efficacy and adverse effects.